The presentation, etiologies, pathophysiology, and treatment of pulmonary renal syndrome: A review of the literature. [Review] - 2022

Available online from MWHC library: 2001 - present

Pulmonary renal syndrome (PRS) is a constellation of different disorders that cause both rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage. While antineutrophil cytoplasmic antibody associated vasculitis and anti-glomerular basement membrane disease are the predominant causes of PRS, numerous other mechanisms have been shown to cause this syndrome, including thrombotic microangiopathies, drug exposures, and infections, among others. This syndrome has high morbidity and mortality, and early diagnosis and treatment is imperative to improve outcomes. Treatment generally involves glucocorticoids and immunosuppressive agents, but treatment targeted to the underlying disorder can improve outcomes and mitigate side effects. Familiarity with the wide range of possible causes of PRS can aid the clinician in workup, diagnosis and early initiation of treatment. This review provides a summary of the clinical presentation, etiologies, pathophysiology, and treatment of PRS. Copyright © 2022 Elsevier Inc. All rights reserved.


English

0011-5029

10.1016/j.disamonth.2022.101465 [doi] S0011-5029(22)00149-3 [pii]


*Anti-Glomerular Basement Membrane Disease
*Glomerulonephritis
*Lung Diseases
Anti-Glomerular Basement Membrane Disease/co [Complications]
Anti-Glomerular Basement Membrane Disease/di [Diagnosis]
Antibodies, Antineutrophil Cytoplasmic/tu [Therapeutic Use]
Glomerulonephritis/di [Diagnosis]
Glomerulonephritis/et [Etiology]
Glomerulonephritis/th [Therapy]
Hemorrhage/di [Diagnosis]
Hemorrhage/et [Etiology]
Hemorrhage/th [Therapy]
Humans
Immunosuppressive Agents/tu [Therapeutic Use]
Lung Diseases/di [Diagnosis]
Lung Diseases/et [Etiology]
Lung Diseases/th [Therapy]


Internal Medicine & Pediatrics Residency
MedStar Georgetown University Hospital/MedStar Washington Hospital Center


Journal Article
Review